# Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

> **NCT01517945** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 252 (actual)

## Conditions studied

- Breast Cancer
- Rare Cancer

## Interventions

- **BEHAVIORAL:** AIM materials and assessments

## Key facts

- **NCT ID:** NCT01517945
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517945, "Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01517945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*